FDA Announces Voluntary Recall of Several Medicines Containing Valsartan Following Detection of an Impurity

July 13, 2018 -- The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure....

https://ift.tt/2uzDF1t